0.1044
price up icon7.08%   0.0069
after-market 시간 외 거래: .10 -0.0044 -4.21%
loading
전일 마감가:
$0.0975
열려 있는:
$0.104
하루 거래량:
4.80M
Relative Volume:
0.18
시가총액:
$9.02M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+9.78%
1개월 성능:
+45.40%
6개월 성능:
-84.65%
1년 성능:
+0.00%
1일 변동 폭
Value
$0.0961
$0.1066
1주일 범위
Value
$0.0934
$0.121
52주 변동 폭
Value
$0.0651
$2.22

Profusa Inc Stock (PFSA) Company Profile

Name
명칭
Profusa Inc
Name
전화
212-494-9022
Name
주소
207 WEST 25TH ST, 9TH FLOOR, NEW YORK
Name
직원
0
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
PFSA's Discussions on Twitter

PFSA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
PFSA
Profusa Inc
0.1044 8.43M 0 0 0 0.00
Medical Devices icon
ABT
Abbott Laboratories
108.27 189.14B 44.33B 6.48B 6.92B 3.7033
Medical Devices icon
BSX
Boston Scientific Corp
93.61 138.74B 19.35B 2.78B 3.82B 1.8696
Medical Devices icon
SYK
Stryker Corp
354.57 136.52B 24.38B 2.94B 4.07B 7.6159
Medical Devices icon
MDT
Medtronic Plc
100.69 129.06B 34.76B 4.79B 5.21B 3.7017
Medical Devices icon
EW
Edwards Lifesciences Corp
83.60 48.90B 5.88B 1.34B 799.60M 2.3489

Profusa Inc 주식(PFSA)의 최신 뉴스

pulisher
02:24 AM

Contrasting Profusa (NASDAQ:PFSA) & Longevity Health (NASDAQ:XAGE) - Defense World

02:24 AM
pulisher
Jan 17, 2026

Profusa restructures senior secured convertible notes - MSN

Jan 17, 2026
pulisher
Jan 17, 2026

Profusa launches tissue oxygen monitoring system for research market By Investing.com - Investing.com Nigeria

Jan 17, 2026
pulisher
Jan 16, 2026

Profusa Stock Spikes As Lumee System Targets Research Market - Benzinga

Jan 16, 2026
pulisher
Jan 16, 2026

Profusa Launches Lumee, Paving Way For First Commercial Revenue; Stock Jumps - Nasdaq

Jan 16, 2026
pulisher
Jan 16, 2026

Profusa launches tissue oxygen monitoring system for research market - Investing.com

Jan 16, 2026
pulisher
Jan 16, 2026

Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First ... - Bluefield Daily Telegraph

Jan 16, 2026
pulisher
Jan 16, 2026

Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue - GlobeNewswire

Jan 16, 2026
pulisher
Jan 16, 2026

Drug trials get new oxygen sensor as Profusa enters $47.9B CRO market - Stock Titan

Jan 16, 2026
pulisher
Jan 15, 2026

NorthView Acquisition Corp Announces Filing a Registration Statement on Form S-4 in Connection with a Proposed Business Combination with Profusa, Inc. - Intellectia AI

Jan 15, 2026
pulisher
Jan 09, 2026

Profusa, Inc.Common Stock (NQ: PFSA - FinancialContent

Jan 09, 2026
pulisher
Jan 08, 2026

Profusa Adds Leading Greek Vascular Surgeon to Customer Base - manilatimes.net

Jan 08, 2026
pulisher
Jan 07, 2026

Contact | Statesman-ExaminerProfusa, Inc.Common Stock (Nasdaq:PFSA) Stock Quote - FinancialContent

Jan 07, 2026
pulisher
Jan 02, 2026

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Jan 02, 2026
pulisher
Jan 02, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Jan 02, 2026
pulisher
Jan 02, 2026

Profusa (NASDAQ: PFSA) outlines reverse split plan to address Nasdaq listing rules - Stock Titan

Jan 02, 2026
pulisher
Dec 31, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Dec 31, 2025
pulisher
Dec 31, 2025

Profusa expands European footprint with French distributor partnership By Investing.com - Investing.com Nigeria

Dec 31, 2025
pulisher
Dec 31, 2025

Profusa expands European footprint with French distributor partnership - Investing.com India

Dec 31, 2025
pulisher
Dec 31, 2025

Profusa Bolsters European Commercial Network with New French Distributor, MedSell - The Manila Times

Dec 31, 2025
pulisher
Dec 31, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Dec 31, 2025
pulisher
Dec 31, 2025

Profusa stock whipsaws: PFSA dips premarket after 78% surge on debt restructuring - ts2.tech

Dec 31, 2025
pulisher
Dec 31, 2025

Manufacturing Stocks To Add to Your Watchlist – December 30th - Defense World

Dec 31, 2025
pulisher
Dec 30, 2025

Nio, Profusa, Nike, FTAI Aviation And Under Armour: Why These 5 Stocks Are On Investors' Radars Today - Benzinga

Dec 30, 2025
pulisher
Dec 30, 2025

Profusa (PFSA) Stock Analysis Report | Financials & Insights - Benzinga

Dec 30, 2025
pulisher
Dec 30, 2025

Profusa Stock Soars—To 12 Cents—On Debt Restructuring - Sahm

Dec 30, 2025
pulisher
Dec 30, 2025

Profusa (PFSA) Stock: Announces Key Changes to Senior Secured Convertible Notes for Stronger Financial Health - parameter.io

Dec 30, 2025
pulisher
Dec 30, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Dec 30, 2025
pulisher
Dec 30, 2025

Nasdaq Trading Activity: Profusa Leads High-Volume Movers on December 30, 2025News and Statistics - IndexBox

Dec 30, 2025
pulisher
Dec 30, 2025

Profusa amends securities purchase agreement to allow for $5 million note sale - Investing.com Nigeria

Dec 30, 2025
pulisher
Dec 30, 2025

Here’s Why Profusa Stock (PFSA) Rocketed Today - TipRanks

Dec 30, 2025
pulisher
Dec 30, 2025

US Stocks Lower; Home Price Growth Eases in October - Sahm

Dec 30, 2025
pulisher
Dec 30, 2025

Profusa Restructures Senior Secured Convertible Notes; Shares Jump Pre-Bell - marketscreener.com

Dec 30, 2025
pulisher
Dec 30, 2025

Profusa restructures convertible note to reduce dilution, increase flexibility - Investing.com

Dec 30, 2025
pulisher
Dec 30, 2025

Profusa amends securities purchase agreement to allow for $5 million note sale By Investing.com - Investing.com South Africa

Dec 30, 2025
pulisher
Dec 30, 2025

Profusa restructures convertible note to reduce dilution, increase flexibility By Investing.com - Investing.com South Africa

Dec 30, 2025
pulisher
Dec 30, 2025

Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35 - The Manila Times

Dec 30, 2025
pulisher
Dec 30, 2025

Profusa Signs Amendment No. 3 to Securities Purchase Agreement With Ascent Partners Fund - TradingView — Track All Markets

Dec 30, 2025
pulisher
Dec 30, 2025

[8-K] Profusa, Inc. Reports Material Event | PFSA SEC FilingForm 8-K - Stock Titan

Dec 30, 2025
pulisher
Dec 29, 2025

Profusa amends securities purchase agreement to expand financing - MSN

Dec 29, 2025
pulisher
Dec 25, 2025

PFSA SEC FilingsProfusa Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Dec 25, 2025
pulisher
Dec 23, 2025

Profusa amends equity deal and convertible note terms - MSN

Dec 23, 2025
pulisher
Dec 23, 2025

[424B3] Profusa, Inc. Prospectus Filed Pursuant to Rule 424(b)(3) - Stock Titan

Dec 23, 2025
pulisher
Dec 23, 2025

Profusa amends securities agreements with Ascent Partners Fund By Investing.com - Investing.com Nigeria

Dec 23, 2025
pulisher
Dec 23, 2025

Profusa Amends Equity Deal and Convertible Note Terms - TipRanks

Dec 23, 2025
pulisher
Dec 23, 2025

Profusa amends securities agreements with Ascent Partners Fund - Investing.com

Dec 23, 2025
pulisher
Dec 23, 2025

Profusa Updates Multiple Financing Agreements With Ascent Partners Fund - TradingView — Track All Markets

Dec 23, 2025
pulisher
Dec 22, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Dec 22, 2025
pulisher
Dec 19, 2025

Profusa (NASDAQ: NVACW) details reverse split plan and Nasdaq deficiency risks - Stock Titan

Dec 19, 2025
pulisher
Dec 17, 2025

Profusa (NASDAQ:PFSA) versus ReShape Lifesciences (OTCMKTS:RSLSD) Financial Contrast - Defense World

Dec 17, 2025

Profusa Inc (PFSA) 재무 분석

Profusa Inc (PFSA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$264.91
price down icon 2.37%
medical_devices STE
$263.07
price down icon 0.02%
medical_devices PHG
$29.52
price up icon 0.96%
$73.67
price up icon 0.45%
$80.32
price up icon 0.06%
medical_devices EW
$83.60
price down icon 0.80%
자본화:     |  볼륨(24시간):